Strategy Asset Managers LLC bought a new position in shares of Boston Scientific Co. (NYSE:BSX – Get Rating) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 8,108 shares of the medical equipment provider’s stock, valued at approximately $344,000. A number of other […]